nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2E1—Dacarbazine—muscle cancer	0.126	0.207	CbGbCtD
Nicardipine—CYP2E1—Etoposide—muscle cancer	0.0618	0.101	CbGbCtD
Nicardipine—ABCB1—Dactinomycin—muscle cancer	0.0554	0.0906	CbGbCtD
Nicardipine—CYP3A5—Vincristine—muscle cancer	0.0524	0.0858	CbGbCtD
Nicardipine—CYP3A5—Etoposide—muscle cancer	0.048	0.0786	CbGbCtD
Nicardipine—CYP2C8—Etoposide—muscle cancer	0.0462	0.0756	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—muscle cancer	0.0416	0.068	CbGbCtD
Nicardipine—ABCB1—Vincristine—muscle cancer	0.0341	0.0558	CbGbCtD
Nicardipine—ABCB1—Etoposide—muscle cancer	0.0313	0.0511	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—muscle cancer	0.0213	0.0349	CbGbCtD
Nicardipine—ABCB1—Methotrexate—muscle cancer	0.0207	0.0338	CbGbCtD
Nicardipine—CYP3A4—Vincristine—muscle cancer	0.0204	0.0334	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—muscle cancer	0.0201	0.0329	CbGbCtD
Nicardipine—CYP3A4—Etoposide—muscle cancer	0.0187	0.0306	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—muscle cancer	0.0128	0.0209	CbGbCtD
Nicardipine—CHRM3—muscle of abdomen—muscle cancer	0.0124	0.0967	CbGeAlD
Nicardipine—PDE1A—smooth muscle tissue—muscle cancer	0.00355	0.0278	CbGeAlD
Nicardipine—PDE1A—renal system—muscle cancer	0.00342	0.0267	CbGeAlD
Nicardipine—Electrocardiogram ST segment depression—Doxorubicin—muscle cancer	0.00275	0.0315	CcSEcCtD
Nicardipine—PDE1B—head—muscle cancer	0.00273	0.0213	CbGeAlD
Nicardipine—PDE1A—tendon—muscle cancer	0.00267	0.0209	CbGeAlD
Nicardipine—PDE1B—testis—muscle cancer	0.00264	0.0206	CbGeAlD
Nicardipine—PDE1A—head—muscle cancer	0.00229	0.0179	CbGeAlD
Nicardipine—CACNB2—cardiac atrium—muscle cancer	0.00226	0.0176	CbGeAlD
Nicardipine—ADRA1B—renal system—muscle cancer	0.00223	0.0175	CbGeAlD
Nicardipine—PDE1A—testis—muscle cancer	0.00221	0.0173	CbGeAlD
Nicardipine—CACNA1C—smooth muscle tissue—muscle cancer	0.00211	0.0165	CbGeAlD
Nicardipine—CHRM4—head—muscle cancer	0.00209	0.0164	CbGeAlD
Nicardipine—CHRM4—testis—muscle cancer	0.00202	0.0158	CbGeAlD
Nicardipine—CACNA1D—cardiac atrium—muscle cancer	0.00197	0.0154	CbGeAlD
Nicardipine—CACNB2—tendon—muscle cancer	0.00197	0.0154	CbGeAlD
Nicardipine—CACNA2D1—tendon—muscle cancer	0.00185	0.0144	CbGeAlD
Nicardipine—CACNB2—vagina—muscle cancer	0.00183	0.0143	CbGeAlD
Nicardipine—CACNA1C—cardiac atrium—muscle cancer	0.00182	0.0142	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—muscle cancer	0.00179	0.014	CbGeAlD
Nicardipine—CALM3—smooth muscle tissue—muscle cancer	0.00177	0.0138	CbGeAlD
Nicardipine—CALM2—embryo—muscle cancer	0.00177	0.0138	CbGeAlD
Nicardipine—CALM1—embryo—muscle cancer	0.00176	0.0137	CbGeAlD
Nicardipine—CACNA2D1—vagina—muscle cancer	0.00172	0.0134	CbGeAlD
Nicardipine—CACNB2—head—muscle cancer	0.00169	0.0132	CbGeAlD
Nicardipine—Pericarditis—Methotrexate—muscle cancer	0.00167	0.0191	CcSEcCtD
Nicardipine—CHRM5—head—muscle cancer	0.00164	0.0128	CbGeAlD
Nicardipine—CACNB2—testis—muscle cancer	0.00163	0.0127	CbGeAlD
Nicardipine—CACNA2D1—head—muscle cancer	0.00158	0.0124	CbGeAlD
Nicardipine—CACNA2D1—testis—muscle cancer	0.00153	0.012	CbGeAlD
Nicardipine—CALM3—cardiac atrium—muscle cancer	0.00153	0.0119	CbGeAlD
Nicardipine—ADRA1B—head—muscle cancer	0.00149	0.0117	CbGeAlD
Nicardipine—CACNA1D—head—muscle cancer	0.00147	0.0115	CbGeAlD
Nicardipine—CACNA1C—vagina—muscle cancer	0.00147	0.0115	CbGeAlD
Nicardipine—ADRA1D—head—muscle cancer	0.00146	0.0114	CbGeAlD
Nicardipine—Pericarditis—Doxorubicin—muscle cancer	0.00144	0.0166	CcSEcCtD
Nicardipine—CACNA1D—testis—muscle cancer	0.00142	0.0111	CbGeAlD
Nicardipine—CHRM3—smooth muscle tissue—muscle cancer	0.00142	0.0111	CbGeAlD
Nicardipine—CALM2—smooth muscle tissue—muscle cancer	0.00139	0.0109	CbGeAlD
Nicardipine—CALM1—smooth muscle tissue—muscle cancer	0.00138	0.0108	CbGeAlD
Nicardipine—CHRM3—renal system—muscle cancer	0.00137	0.0107	CbGeAlD
Nicardipine—CACNA1C—head—muscle cancer	0.00136	0.0106	CbGeAlD
Nicardipine—Urine output increased—Vincristine—muscle cancer	0.00134	0.0154	CcSEcCtD
Nicardipine—CALM2—renal system—muscle cancer	0.00134	0.0105	CbGeAlD
Nicardipine—CALM1—renal system—muscle cancer	0.00133	0.0104	CbGeAlD
Nicardipine—CALM3—tendon—muscle cancer	0.00133	0.0104	CbGeAlD
Nicardipine—CACNA1C—testis—muscle cancer	0.00131	0.0103	CbGeAlD
Nicardipine—CALM3—bone marrow—muscle cancer	0.00129	0.0101	CbGeAlD
Nicardipine—Peripheral vascular disorder—Doxorubicin—muscle cancer	0.00127	0.0146	CcSEcCtD
Nicardipine—ADRA1A—renal system—muscle cancer	0.00126	0.00981	CbGeAlD
Nicardipine—CALM3—vagina—muscle cancer	0.00123	0.00964	CbGeAlD
Nicardipine—Polyuria—Vincristine—muscle cancer	0.00123	0.0141	CcSEcCtD
Nicardipine—CALM2—cardiac atrium—muscle cancer	0.0012	0.00936	CbGeAlD
Nicardipine—CALM1—cardiac atrium—muscle cancer	0.00119	0.00932	CbGeAlD
Nicardipine—Deep vein thrombosis—Methotrexate—muscle cancer	0.00119	0.0136	CcSEcCtD
Nicardipine—CHRM2—head—muscle cancer	0.00112	0.00877	CbGeAlD
Nicardipine—CYP2C8—renal system—muscle cancer	0.00111	0.00867	CbGeAlD
Nicardipine—CALM3—testis—muscle cancer	0.0011	0.00861	CbGeAlD
Nicardipine—Hypophosphataemia—Doxorubicin—muscle cancer	0.00107	0.0123	CcSEcCtD
Nicardipine—CALM2—tendon—muscle cancer	0.00104	0.00816	CbGeAlD
Nicardipine—CALM1—tendon—muscle cancer	0.00104	0.00812	CbGeAlD
Nicardipine—CHRM1—head—muscle cancer	0.00102	0.00799	CbGeAlD
Nicardipine—CALM2—bone marrow—muscle cancer	0.00101	0.00791	CbGeAlD
Nicardipine—CALM1—bone marrow—muscle cancer	0.00101	0.00787	CbGeAlD
Nicardipine—CYP3A5—renal system—muscle cancer	0.001	0.00782	CbGeAlD
Nicardipine—CYP2B6—renal system—muscle cancer	0.000995	0.00777	CbGeAlD
Nicardipine—CALM2—vagina—muscle cancer	0.000969	0.00757	CbGeAlD
Nicardipine—CALM1—vagina—muscle cancer	0.000965	0.00754	CbGeAlD
Nicardipine—CYP2E1—renal system—muscle cancer	0.000934	0.00729	CbGeAlD
Nicardipine—CYP2C19—vagina—muscle cancer	0.00092	0.00719	CbGeAlD
Nicardipine—CHRM3—head—muscle cancer	0.000915	0.00715	CbGeAlD
Nicardipine—CALM2—head—muscle cancer	0.000895	0.007	CbGeAlD
Nicardipine—CALM1—head—muscle cancer	0.000891	0.00696	CbGeAlD
Nicardipine—CHRM3—testis—muscle cancer	0.000884	0.0069	CbGeAlD
Nicardipine—CALM2—testis—muscle cancer	0.000865	0.00676	CbGeAlD
Nicardipine—CALM1—testis—muscle cancer	0.000861	0.00673	CbGeAlD
Nicardipine—Erectile dysfunction—Vincristine—muscle cancer	0.000859	0.00985	CcSEcCtD
Nicardipine—ADRA1A—head—muscle cancer	0.00084	0.00656	CbGeAlD
Nicardipine—Acute coronary syndrome—Vincristine—muscle cancer	0.00082	0.0094	CcSEcCtD
Nicardipine—Myocardial infarction—Vincristine—muscle cancer	0.000815	0.00934	CcSEcCtD
Nicardipine—CYP2C8—vagina—muscle cancer	0.000803	0.00628	CbGeAlD
Nicardipine—Sweating—Vincristine—muscle cancer	0.000797	0.00914	CcSEcCtD
Nicardipine—Flushing—Dactinomycin—muscle cancer	0.000776	0.00889	CcSEcCtD
Nicardipine—Injection site pain—Doxorubicin—muscle cancer	0.000765	0.00877	CcSEcCtD
Nicardipine—CYP3A4—renal system—muscle cancer	0.000751	0.00587	CbGeAlD
Nicardipine—Hypoaesthesia—Vincristine—muscle cancer	0.000743	0.00851	CcSEcCtD
Nicardipine—CYP2D6—renal system—muscle cancer	0.000739	0.00578	CbGeAlD
Nicardipine—Sweating increased—Etoposide—muscle cancer	0.000736	0.00844	CcSEcCtD
Nicardipine—CYP2E1—tendon—muscle cancer	0.000729	0.00569	CbGeAlD
Nicardipine—CYP3A5—vagina—muscle cancer	0.000725	0.00566	CbGeAlD
Nicardipine—CYP2B6—vagina—muscle cancer	0.000721	0.00563	CbGeAlD
Nicardipine—CYP2C8—testis—muscle cancer	0.000717	0.0056	CbGeAlD
Nicardipine—Vasodilation procedure—Doxorubicin—muscle cancer	0.000711	0.00815	CcSEcCtD
Nicardipine—Vasodilation—Doxorubicin—muscle cancer	0.000711	0.00815	CcSEcCtD
Nicardipine—ABCB1—embryo—muscle cancer	0.000703	0.00549	CbGeAlD
Nicardipine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.000692	0.00793	CcSEcCtD
Nicardipine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000675	0.00774	CcSEcCtD
Nicardipine—Nocturia—Doxorubicin—muscle cancer	0.000673	0.00772	CcSEcCtD
Nicardipine—CYP2B6—head—muscle cancer	0.000666	0.0052	CbGeAlD
Nicardipine—Acute coronary syndrome—Etoposide—muscle cancer	0.000664	0.00761	CcSEcCtD
Nicardipine—Myocardial infarction—Etoposide—muscle cancer	0.00066	0.00757	CcSEcCtD
Nicardipine—Malaise—Dactinomycin—muscle cancer	0.000656	0.00752	CcSEcCtD
Nicardipine—Urine output increased—Methotrexate—muscle cancer	0.000652	0.00747	CcSEcCtD
Nicardipine—Atrioventricular block—Doxorubicin—muscle cancer	0.000644	0.00738	CcSEcCtD
Nicardipine—CYP2B6—testis—muscle cancer	0.000643	0.00502	CbGeAlD
Nicardipine—Neck pain—Doxorubicin—muscle cancer	0.000632	0.00725	CcSEcCtD
Nicardipine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000625	0.00716	CcSEcCtD
Nicardipine—CYP2E1—head—muscle cancer	0.000625	0.00488	CbGeAlD
Nicardipine—Injection site reaction—Doxorubicin—muscle cancer	0.000621	0.00712	CcSEcCtD
Nicardipine—Myalgia—Dactinomycin—muscle cancer	0.000619	0.0071	CcSEcCtD
Nicardipine—Abnormal dreams—Doxorubicin—muscle cancer	0.000617	0.00707	CcSEcCtD
Nicardipine—Discomfort—Dactinomycin—muscle cancer	0.000612	0.00701	CcSEcCtD
Nicardipine—CYP2E1—testis—muscle cancer	0.000603	0.00471	CbGeAlD
Nicardipine—Hypoaesthesia—Etoposide—muscle cancer	0.000602	0.0069	CcSEcCtD
Nicardipine—Agitation—Vincristine—muscle cancer	0.000597	0.00684	CcSEcCtD
Nicardipine—Polyuria—Methotrexate—muscle cancer	0.000596	0.00683	CcSEcCtD
Nicardipine—Oedema—Dactinomycin—muscle cancer	0.000594	0.0068	CcSEcCtD
Nicardipine—Infection—Dactinomycin—muscle cancer	0.00059	0.00676	CcSEcCtD
Nicardipine—Vertigo—Vincristine—muscle cancer	0.000584	0.00669	CcSEcCtD
Nicardipine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000581	0.00666	CcSEcCtD
Nicardipine—Flushing—Etoposide—muscle cancer	0.000561	0.00643	CcSEcCtD
Nicardipine—Hypertension—Vincristine—muscle cancer	0.000561	0.00643	CcSEcCtD
Nicardipine—Myalgia—Vincristine—muscle cancer	0.000553	0.00634	CcSEcCtD
Nicardipine—Hypertonia—Doxorubicin—muscle cancer	0.000548	0.00628	CcSEcCtD
Nicardipine—Abnormal vision—Doxorubicin—muscle cancer	0.000545	0.00624	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000541	0.0062	CcSEcCtD
Nicardipine—ABCB1—renal system—muscle cancer	0.000532	0.00415	CbGeAlD
Nicardipine—Oedema—Vincristine—muscle cancer	0.00053	0.00608	CcSEcCtD
Nicardipine—Infection—Vincristine—muscle cancer	0.000527	0.00604	CcSEcCtD
Nicardipine—Thrombocytopenia—Vincristine—muscle cancer	0.000519	0.00595	CcSEcCtD
Nicardipine—Hyperhidrosis—Vincristine—muscle cancer	0.000513	0.00588	CcSEcCtD
Nicardipine—Pain—Dactinomycin—muscle cancer	0.000508	0.00582	CcSEcCtD
Nicardipine—Hypotension—Vincristine—muscle cancer	0.000496	0.00568	CcSEcCtD
Nicardipine—CYP2D6—head—muscle cancer	0.000495	0.00386	CbGeAlD
Nicardipine—Feeling abnormal—Dactinomycin—muscle cancer	0.000489	0.00561	CcSEcCtD
Nicardipine—Ill-defined disorder—Etoposide—muscle cancer	0.000489	0.0056	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000486	0.00556	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—muscle cancer	0.000485	0.00556	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000483	0.00554	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—muscle cancer	0.000481	0.00551	CcSEcCtD
Nicardipine—Insomnia—Vincristine—muscle cancer	0.00048	0.0055	CcSEcCtD
Nicardipine—CYP2D6—testis—muscle cancer	0.000478	0.00373	CbGeAlD
Nicardipine—Paraesthesia—Vincristine—muscle cancer	0.000476	0.00546	CcSEcCtD
Nicardipine—Malaise—Etoposide—muscle cancer	0.000475	0.00544	CcSEcCtD
Nicardipine—Vertigo—Etoposide—muscle cancer	0.000473	0.00542	CcSEcCtD
Nicardipine—Body temperature increased—Dactinomycin—muscle cancer	0.000469	0.00538	CcSEcCtD
Nicardipine—Abdominal pain—Dactinomycin—muscle cancer	0.000469	0.00538	CcSEcCtD
Nicardipine—Loss of consciousness—Etoposide—muscle cancer	0.000463	0.0053	CcSEcCtD
Nicardipine—Hypertension—Etoposide—muscle cancer	0.000455	0.00521	CcSEcCtD
Nicardipine—Constipation—Vincristine—muscle cancer	0.000454	0.0052	CcSEcCtD
Nicardipine—Pain—Vincristine—muscle cancer	0.000454	0.0052	CcSEcCtD
Nicardipine—Chest pain—Etoposide—muscle cancer	0.000448	0.00514	CcSEcCtD
Nicardipine—Discomfort—Etoposide—muscle cancer	0.000443	0.00508	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—muscle cancer	0.000438	0.00502	CcSEcCtD
Nicardipine—Hypersensitivity—Dactinomycin—muscle cancer	0.000437	0.00501	CcSEcCtD
Nicardipine—Gastrointestinal pain—Vincristine—muscle cancer	0.000434	0.00497	CcSEcCtD
Nicardipine—Confusional state—Etoposide—muscle cancer	0.000433	0.00497	CcSEcCtD
Nicardipine—Infection—Etoposide—muscle cancer	0.000427	0.00489	CcSEcCtD
Nicardipine—Asthenia—Dactinomycin—muscle cancer	0.000426	0.00488	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—muscle cancer	0.000421	0.00482	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—muscle cancer	0.000419	0.00481	CcSEcCtD
Nicardipine—Body temperature increased—Vincristine—muscle cancer	0.000419	0.00481	CcSEcCtD
Nicardipine—Abdominal pain—Vincristine—muscle cancer	0.000419	0.00481	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—muscle cancer	0.000417	0.00478	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—muscle cancer	0.000415	0.00476	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000414	0.00475	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—muscle cancer	0.000413	0.00473	CcSEcCtD
Nicardipine—Diarrhoea—Dactinomycin—muscle cancer	0.000406	0.00466	CcSEcCtD
Nicardipine—ABCB1—bone marrow—muscle cancer	0.000402	0.00314	CbGeAlD
Nicardipine—Hypotension—Etoposide—muscle cancer	0.000402	0.0046	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—muscle cancer	0.000392	0.0045	CcSEcCtD
Nicardipine—Hypersensitivity—Vincristine—muscle cancer	0.000391	0.00448	CcSEcCtD
Nicardipine—Sweating—Methotrexate—muscle cancer	0.000387	0.00443	CcSEcCtD
Nicardipine—Paraesthesia—Etoposide—muscle cancer	0.000386	0.00442	CcSEcCtD
Nicardipine—ABCB1—vagina—muscle cancer	0.000385	0.00301	CbGeAlD
Nicardipine—Haematuria—Methotrexate—muscle cancer	0.000385	0.00441	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—muscle cancer	0.000383	0.00439	CcSEcCtD
Nicardipine—Somnolence—Etoposide—muscle cancer	0.000382	0.00438	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—muscle cancer	0.000382	0.00438	CcSEcCtD
Nicardipine—Asthenia—Vincristine—muscle cancer	0.000381	0.00436	CcSEcCtD
Nicardipine—Vomiting—Dactinomycin—muscle cancer	0.000377	0.00433	CcSEcCtD
Nicardipine—Rash—Dactinomycin—muscle cancer	0.000374	0.00429	CcSEcCtD
Nicardipine—Pain—Etoposide—muscle cancer	0.000367	0.00421	CcSEcCtD
Nicardipine—Constipation—Etoposide—muscle cancer	0.000367	0.00421	CcSEcCtD
Nicardipine—Diarrhoea—Vincristine—muscle cancer	0.000363	0.00416	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—muscle cancer	0.000362	0.00415	CcSEcCtD
Nicardipine—ABCB1—head—muscle cancer	0.000356	0.00278	CbGeAlD
Nicardipine—Feeling abnormal—Etoposide—muscle cancer	0.000354	0.00406	CcSEcCtD
Nicardipine—Nausea—Dactinomycin—muscle cancer	0.000353	0.00404	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—muscle cancer	0.000351	0.00403	CcSEcCtD
Nicardipine—Dizziness—Vincristine—muscle cancer	0.000351	0.00402	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—muscle cancer	0.000349	0.004	CcSEcCtD
Nicardipine—ABCB1—testis—muscle cancer	0.000344	0.00269	CbGeAlD
Nicardipine—Abdominal pain—Etoposide—muscle cancer	0.00034	0.00389	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—muscle cancer	0.00034	0.00389	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—muscle cancer	0.00034	0.00389	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—muscle cancer	0.000338	0.00387	CcSEcCtD
Nicardipine—Vomiting—Vincristine—muscle cancer	0.000337	0.00387	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—muscle cancer	0.000335	0.00384	CcSEcCtD
Nicardipine—Rash—Vincristine—muscle cancer	0.000334	0.00383	CcSEcCtD
Nicardipine—Dermatitis—Vincristine—muscle cancer	0.000334	0.00383	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—muscle cancer	0.000333	0.00382	CcSEcCtD
Nicardipine—Headache—Vincristine—muscle cancer	0.000332	0.00381	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—muscle cancer	0.000328	0.00376	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—muscle cancer	0.000317	0.00363	CcSEcCtD
Nicardipine—Nausea—Vincristine—muscle cancer	0.000315	0.00361	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—muscle cancer	0.000314	0.0036	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000312	0.00358	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—muscle cancer	0.000309	0.00354	CcSEcCtD
Nicardipine—Asthenia—Etoposide—muscle cancer	0.000308	0.00353	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—muscle cancer	0.000302	0.00346	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—muscle cancer	0.000297	0.00341	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—muscle cancer	0.000294	0.00337	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—muscle cancer	0.000293	0.00335	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—muscle cancer	0.000292	0.00335	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—muscle cancer	0.000291	0.00334	CcSEcCtD
Nicardipine—Malaise—Methotrexate—muscle cancer	0.000284	0.00326	CcSEcCtD
Nicardipine—Dizziness—Etoposide—muscle cancer	0.000284	0.00326	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—muscle cancer	0.000283	0.00325	CcSEcCtD
Nicardipine—Vomiting—Etoposide—muscle cancer	0.000273	0.00313	CcSEcCtD
Nicardipine—Rash—Etoposide—muscle cancer	0.000271	0.0031	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—muscle cancer	0.000271	0.0031	CcSEcCtD
Nicardipine—Headache—Etoposide—muscle cancer	0.000269	0.00308	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—muscle cancer	0.000268	0.00308	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—muscle cancer	0.000268	0.00308	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—muscle cancer	0.000268	0.00308	CcSEcCtD
Nicardipine—Tension—Doxorubicin—muscle cancer	0.000268	0.00307	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—muscle cancer	0.000265	0.00304	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—muscle cancer	0.000265	0.00304	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—muscle cancer	0.00026	0.00297	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—muscle cancer	0.000257	0.00295	CcSEcCtD
Nicardipine—Infection—Methotrexate—muscle cancer	0.000256	0.00293	CcSEcCtD
Nicardipine—Nausea—Etoposide—muscle cancer	0.000255	0.00293	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000253	0.0029	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—muscle cancer	0.000252	0.00289	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—muscle cancer	0.000251	0.00288	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—muscle cancer	0.000249	0.00285	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—muscle cancer	0.000246	0.00282	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—muscle cancer	0.000245	0.00281	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—muscle cancer	0.000245	0.00281	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—muscle cancer	0.000241	0.00277	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—muscle cancer	0.000241	0.00276	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—muscle cancer	0.00024	0.00275	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—muscle cancer	0.000236	0.0027	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000235	0.00269	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—muscle cancer	0.000233	0.00267	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—muscle cancer	0.000232	0.00266	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—muscle cancer	0.000232	0.00266	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—muscle cancer	0.000232	0.00266	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—muscle cancer	0.000232	0.00266	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—muscle cancer	0.000231	0.00265	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—muscle cancer	0.00023	0.00263	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—muscle cancer	0.000229	0.00263	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—muscle cancer	0.000229	0.00262	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—muscle cancer	0.000227	0.00261	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—muscle cancer	0.000227	0.0026	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—muscle cancer	0.000225	0.00258	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—muscle cancer	0.000223	0.00255	CcSEcCtD
Nicardipine—Infection—Doxorubicin—muscle cancer	0.000221	0.00254	CcSEcCtD
Nicardipine—Pain—Methotrexate—muscle cancer	0.00022	0.00252	CcSEcCtD
Nicardipine—Shock—Doxorubicin—muscle cancer	0.000219	0.00251	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000218	0.0025	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—muscle cancer	0.000218	0.00249	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000215	0.00247	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—muscle cancer	0.000212	0.00243	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00021	0.00241	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—muscle cancer	0.000208	0.00239	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—muscle cancer	0.000203	0.00233	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—muscle cancer	0.000203	0.00233	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000203	0.00233	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—muscle cancer	0.000202	0.00231	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—muscle cancer	0.0002	0.00229	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—muscle cancer	0.000199	0.00228	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—muscle cancer	0.000198	0.00227	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—muscle cancer	0.000196	0.00225	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—muscle cancer	0.000191	0.00218	CcSEcCtD
Nicardipine—Pain—Doxorubicin—muscle cancer	0.000191	0.00218	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—muscle cancer	0.00019	0.00217	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—muscle cancer	0.000185	0.00212	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—muscle cancer	0.000184	0.0021	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000182	0.00209	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—muscle cancer	0.000176	0.00202	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—muscle cancer	0.000176	0.00202	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—muscle cancer	0.000176	0.00202	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—muscle cancer	0.00017	0.00195	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—muscle cancer	0.000164	0.00188	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—muscle cancer	0.000164	0.00188	CcSEcCtD
Nicardipine—Rash—Methotrexate—muscle cancer	0.000162	0.00186	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—muscle cancer	0.000162	0.00186	CcSEcCtD
Nicardipine—Headache—Methotrexate—muscle cancer	0.000161	0.00185	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—muscle cancer	0.00016	0.00183	CcSEcCtD
Nicardipine—Nausea—Methotrexate—muscle cancer	0.000153	0.00175	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—muscle cancer	0.000152	0.00175	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—muscle cancer	0.000147	0.00169	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—muscle cancer	0.000142	0.00162	CcSEcCtD
Nicardipine—Rash—Doxorubicin—muscle cancer	0.000141	0.00161	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—muscle cancer	0.00014	0.00161	CcSEcCtD
Nicardipine—Headache—Doxorubicin—muscle cancer	0.00014	0.0016	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—muscle cancer	0.000132	0.00152	CcSEcCtD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	7.09e-05	0.000408	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	7.08e-05	0.000408	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—FH—muscle cancer	7.08e-05	0.000408	CbGpPWpGaD
Nicardipine—CALM3—Neuronal System—MDM2—muscle cancer	6.91e-05	0.000398	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	6.83e-05	0.000394	CbGpPWpGaD
Nicardipine—PDE1A—Hemostasis—TP53—muscle cancer	6.79e-05	0.000391	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PTCH1—muscle cancer	6.78e-05	0.000391	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—MDM2—muscle cancer	6.77e-05	0.00039	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—FOXO1—muscle cancer	6.68e-05	0.000385	CbGpPWpGaD
Nicardipine—CALM1—Neuronal System—MDM2—muscle cancer	6.68e-05	0.000385	CbGpPWpGaD
Nicardipine—CALM2—Neuronal System—MDM2—muscle cancer	6.68e-05	0.000385	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—FH—muscle cancer	6.67e-05	0.000384	CbGpPWpGaD
Nicardipine—PDE1B—Disease—KIT—muscle cancer	6.65e-05	0.000383	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IGF2—muscle cancer	6.64e-05	0.000383	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—FH—muscle cancer	6.62e-05	0.000381	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—MDM2—muscle cancer	6.55e-05	0.000377	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—MDM2—muscle cancer	6.55e-05	0.000377	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CNR1—muscle cancer	6.53e-05	0.000376	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CNR1—muscle cancer	6.51e-05	0.000375	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PTCH1—muscle cancer	6.49e-05	0.000374	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	6.46e-05	0.000372	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CNR1—muscle cancer	6.45e-05	0.000371	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—FOXO1—muscle cancer	6.44e-05	0.000371	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	6.43e-05	0.00037	CbGpPWpGaD
Nicardipine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.32e-05	0.000364	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—MED12—muscle cancer	6.31e-05	0.000363	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	6.25e-05	0.00036	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	6.25e-05	0.00036	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—FOXO1—muscle cancer	6.23e-05	0.000359	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—FOXO1—muscle cancer	6.23e-05	0.000359	CbGpPWpGaD
Nicardipine—PDE1B—Hemostasis—TP53—muscle cancer	6.21e-05	0.000358	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—MDM2—muscle cancer	6.2e-05	0.000357	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	6.18e-05	0.000356	CbGpPWpGaD
Nicardipine—CHRM1—Circadian rythm related genes—TP53—muscle cancer	6.17e-05	0.000356	CbGpPWpGaD
Nicardipine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.11e-05	0.000352	CbGpPWpGaD
Nicardipine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.11e-05	0.000352	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—FOXO1—muscle cancer	6.11e-05	0.000352	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PTCH1—muscle cancer	6.11e-05	0.000352	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	5.98e-05	0.000344	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	5.98e-05	0.000344	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—FOXO4—muscle cancer	5.83e-05	0.000336	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—ENO2—muscle cancer	5.75e-05	0.000331	CbGpPWpGaD
Nicardipine—CALM3—Disease—ENO2—muscle cancer	5.75e-05	0.000331	CbGpPWpGaD
Nicardipine—PDE1A—Disease—MDM2—muscle cancer	5.73e-05	0.00033	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CNR1—muscle cancer	5.72e-05	0.00033	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—MDM2—muscle cancer	5.67e-05	0.000327	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—FOXO4—muscle cancer	5.59e-05	0.000322	CbGpPWpGaD
Nicardipine—CALM2—Disease—ENO2—muscle cancer	5.56e-05	0.00032	CbGpPWpGaD
Nicardipine—CALM1—Disease—ENO2—muscle cancer	5.56e-05	0.00032	CbGpPWpGaD
Nicardipine—PDE1A—Disease—PTGS2—muscle cancer	5.52e-05	0.000318	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CNR1—muscle cancer	5.48e-05	0.000316	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CNR1—muscle cancer	5.45e-05	0.000314	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—MED12—muscle cancer	5.43e-05	0.000313	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.38e-05	0.00031	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—MED12—muscle cancer	5.31e-05	0.000306	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—MED12—muscle cancer	5.3e-05	0.000305	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—MED12—muscle cancer	5.28e-05	0.000304	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CNR1—muscle cancer	5.28e-05	0.000304	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CNR1—muscle cancer	5.28e-05	0.000304	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—FOXO4—muscle cancer	5.25e-05	0.000302	CbGpPWpGaD
Nicardipine—PDE1B—Disease—MDM2—muscle cancer	5.24e-05	0.000302	CbGpPWpGaD
Nicardipine—CALM3—Disease—HMGA1—muscle cancer	5.23e-05	0.000301	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CNR1—muscle cancer	5.15e-05	0.000297	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—MED12—muscle cancer	5.11e-05	0.000294	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—MED12—muscle cancer	5.11e-05	0.000294	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—KIT—muscle cancer	5.09e-05	0.000293	CbGpPWpGaD
Nicardipine—CALM3—Immune System—FOXO4—muscle cancer	5.08e-05	0.000292	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	5.07e-05	0.000292	CbGpPWpGaD
Nicardipine—CALM2—Disease—HMGA1—muscle cancer	5.05e-05	0.000291	CbGpPWpGaD
Nicardipine—CALM1—Disease—HMGA1—muscle cancer	5.05e-05	0.000291	CbGpPWpGaD
Nicardipine—PDE1B—Disease—PTGS2—muscle cancer	5.05e-05	0.000291	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—ENO2—muscle cancer	4.95e-05	0.000285	CbGpPWpGaD
Nicardipine—CALM2—Immune System—FOXO4—muscle cancer	4.91e-05	0.000283	CbGpPWpGaD
Nicardipine—CALM1—Immune System—FOXO4—muscle cancer	4.91e-05	0.000283	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—KIT—muscle cancer	4.9e-05	0.000282	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—ENO2—muscle cancer	4.85e-05	0.000279	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—ENO2—muscle cancer	4.84e-05	0.000278	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—ENO2—muscle cancer	4.81e-05	0.000277	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—KIT—muscle cancer	4.74e-05	0.000273	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—KIT—muscle cancer	4.74e-05	0.000273	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—KIT—muscle cancer	4.71e-05	0.000271	CbGpPWpGaD
Nicardipine—CALM3—Disease—FOXO4—muscle cancer	4.69e-05	0.00027	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IGF2—muscle cancer	4.68e-05	0.00027	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—KIT—muscle cancer	4.66e-05	0.000268	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ENO2—muscle cancer	4.66e-05	0.000268	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ENO2—muscle cancer	4.66e-05	0.000268	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—MED12—muscle cancer	4.59e-05	0.000265	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTCH1—muscle cancer	4.57e-05	0.000263	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—PTGS2—muscle cancer	4.57e-05	0.000263	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTCH1—muscle cancer	4.56e-05	0.000263	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—KIT—muscle cancer	4.56e-05	0.000262	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—KIT—muscle cancer	4.56e-05	0.000262	CbGpPWpGaD
Nicardipine—CALM2—Disease—FOXO4—muscle cancer	4.53e-05	0.000261	CbGpPWpGaD
Nicardipine—CALM1—Disease—FOXO4—muscle cancer	4.53e-05	0.000261	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTCH1—muscle cancer	4.51e-05	0.00026	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	4.5e-05	0.000259	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IGF2—muscle cancer	4.48e-05	0.000258	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—FH—muscle cancer	4.36e-05	0.000251	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	4.36e-05	0.000251	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—PTGS2—muscle cancer	4.33e-05	0.000249	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—FOXO1—muscle cancer	4.31e-05	0.000248	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CNR1—muscle cancer	4.28e-05	0.000246	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IGF2—muscle cancer	4.21e-05	0.000243	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ENO2—muscle cancer	4.19e-05	0.000241	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—FOXO1—muscle cancer	4.12e-05	0.000238	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—MED12—muscle cancer	4.1e-05	0.000236	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.07e-05	0.000234	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MDM2—muscle cancer	4.01e-05	0.000231	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—MED12—muscle cancer	4e-05	0.00023	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—FOXO4—muscle cancer	3.93e-05	0.000226	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—FOXO4—muscle cancer	3.92e-05	0.000226	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—FOXO4—muscle cancer	3.88e-05	0.000224	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—FOXO1—muscle cancer	3.88e-05	0.000223	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	3.87e-05	0.000223	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—MDM2—muscle cancer	3.86e-05	0.000222	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CNR1—muscle cancer	3.86e-05	0.000222	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CNR1—muscle cancer	3.85e-05	0.000222	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTCH1—muscle cancer	3.82e-05	0.00022	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CNR1—muscle cancer	3.81e-05	0.000219	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—PTGS2—muscle cancer	3.8e-05	0.000219	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	3.8e-05	0.000219	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—MED12—muscle cancer	3.77e-05	0.000217	CbGpPWpGaD
Nicardipine—CALM3—Immune System—FOXO1—muscle cancer	3.75e-05	0.000216	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—MED12—muscle cancer	3.74e-05	0.000215	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ENO2—muscle cancer	3.74e-05	0.000215	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—MDM2—muscle cancer	3.74e-05	0.000215	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—MDM2—muscle cancer	3.74e-05	0.000215	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—MDM2—muscle cancer	3.71e-05	0.000214	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTCH1—muscle cancer	3.69e-05	0.000213	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTCH1—muscle cancer	3.69e-05	0.000213	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MDM2—muscle cancer	3.67e-05	0.000211	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ENO2—muscle cancer	3.65e-05	0.00021	CbGpPWpGaD
Nicardipine—CALM1—Immune System—FOXO1—muscle cancer	3.63e-05	0.000209	CbGpPWpGaD
Nicardipine—CALM2—Immune System—FOXO1—muscle cancer	3.63e-05	0.000209	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—MDM2—muscle cancer	3.59e-05	0.000207	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—MDM2—muscle cancer	3.59e-05	0.000207	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IGF2—muscle cancer	3.5e-05	0.000201	CbGpPWpGaD
Nicardipine—CALM3—Disease—FOXO1—muscle cancer	3.46e-05	0.000199	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ENO2—muscle cancer	3.44e-05	0.000198	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ENO2—muscle cancer	3.41e-05	0.000196	CbGpPWpGaD
Nicardipine—CALM2—Disease—FOXO1—muscle cancer	3.35e-05	0.000193	CbGpPWpGaD
Nicardipine—CALM1—Disease—FOXO1—muscle cancer	3.35e-05	0.000193	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—FOXO4—muscle cancer	3.28e-05	0.000189	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KIT—muscle cancer	3.28e-05	0.000189	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.28e-05	0.000189	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—VEGFA—muscle cancer	3.26e-05	0.000188	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CNR1—muscle cancer	3.22e-05	0.000186	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	3.22e-05	0.000185	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—FOXO4—muscle cancer	3.17e-05	0.000183	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—FOXO4—muscle cancer	3.17e-05	0.000183	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IGF2—muscle cancer	3.16e-05	0.000182	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—VEGFA—muscle cancer	3.15e-05	0.000181	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—VEGFA—muscle cancer	3.15e-05	0.000181	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IGF2—muscle cancer	3.15e-05	0.000181	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KIT—muscle cancer	3.14e-05	0.000181	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CNR1—muscle cancer	3.12e-05	0.000179	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CNR1—muscle cancer	3.12e-05	0.000179	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IGF2—muscle cancer	3.12e-05	0.000179	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	3.11e-05	0.000179	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—VEGFA—muscle cancer	3.05e-05	0.000175	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KIT—muscle cancer	2.95e-05	0.00017	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.92e-05	0.000168	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—FOXO1—muscle cancer	2.9e-05	0.000167	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—FOXO1—muscle cancer	2.9e-05	0.000167	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—FOXO1—muscle cancer	2.87e-05	0.000165	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	2.86e-05	0.000165	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KIT—muscle cancer	2.86e-05	0.000165	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—VEGFA—muscle cancer	2.79e-05	0.00016	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KIT—muscle cancer	2.76e-05	0.000159	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KIT—muscle cancer	2.76e-05	0.000159	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.67e-05	0.000154	CbGpPWpGaD
Nicardipine—CALM3—Disease—KIT—muscle cancer	2.64e-05	0.000152	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF2—muscle cancer	2.63e-05	0.000152	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MDM2—muscle cancer	2.58e-05	0.000149	CbGpPWpGaD
Nicardipine—CALM1—Disease—KIT—muscle cancer	2.55e-05	0.000147	CbGpPWpGaD
Nicardipine—CALM2—Disease—KIT—muscle cancer	2.55e-05	0.000147	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF2—muscle cancer	2.55e-05	0.000147	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF2—muscle cancer	2.55e-05	0.000147	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MDM2—muscle cancer	2.48e-05	0.000143	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MED12—muscle cancer	2.47e-05	0.000142	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—muscle cancer	2.46e-05	0.000142	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KIT—muscle cancer	2.45e-05	0.000141	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—FOXO1—muscle cancer	2.42e-05	0.00014	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—muscle cancer	2.38e-05	0.000137	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—muscle cancer	2.38e-05	0.000137	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—FOXO1—muscle cancer	2.34e-05	0.000135	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—FOXO1—muscle cancer	2.34e-05	0.000135	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MDM2—muscle cancer	2.33e-05	0.000134	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—muscle cancer	2.3e-05	0.000133	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MDM2—muscle cancer	2.25e-05	0.00013	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ENO2—muscle cancer	2.25e-05	0.000129	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KIT—muscle cancer	2.21e-05	0.000127	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KIT—muscle cancer	2.21e-05	0.000127	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KIT—muscle cancer	2.18e-05	0.000126	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KIT—muscle cancer	2.18e-05	0.000125	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MDM2—muscle cancer	2.18e-05	0.000125	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MDM2—muscle cancer	2.18e-05	0.000125	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—muscle cancer	2.1e-05	0.000121	CbGpPWpGaD
Nicardipine—CALM3—Disease—MDM2—muscle cancer	2.08e-05	0.00012	CbGpPWpGaD
Nicardipine—CALM1—Disease—MDM2—muscle cancer	2.01e-05	0.000116	CbGpPWpGaD
Nicardipine—CALM2—Disease—MDM2—muscle cancer	2.01e-05	0.000116	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—muscle cancer	2e-05	0.000115	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—muscle cancer	2e-05	0.000115	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—VEGFA—muscle cancer	1.96e-05	0.000113	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—muscle cancer	1.94e-05	0.000112	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—muscle cancer	1.94e-05	0.000112	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MDM2—muscle cancer	1.93e-05	0.000111	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—VEGFA—muscle cancer	1.88e-05	0.000108	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KIT—muscle cancer	1.85e-05	0.000106	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KIT—muscle cancer	1.79e-05	0.000103	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KIT—muscle cancer	1.79e-05	0.000103	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—muscle cancer	1.77e-05	0.000102	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MDM2—muscle cancer	1.74e-05	0.0001	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MDM2—muscle cancer	1.74e-05	0.0001	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—muscle cancer	1.72e-05	9.92e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MDM2—muscle cancer	1.72e-05	9.91e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	1.72e-05	9.88e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—muscle cancer	1.69e-05	9.72e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—muscle cancer	1.68e-05	9.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—muscle cancer	1.68e-05	9.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—muscle cancer	1.62e-05	9.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—muscle cancer	1.62e-05	9.34e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—muscle cancer	1.48e-05	8.54e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.47e-05	8.45e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—muscle cancer	1.46e-05	8.4e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MDM2—muscle cancer	1.45e-05	8.38e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—muscle cancer	1.42e-05	8.18e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—muscle cancer	1.41e-05	8.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—muscle cancer	1.41e-05	8.1e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—muscle cancer	1.34e-05	7.69e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—muscle cancer	1.32e-05	7.62e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—muscle cancer	1.32e-05	7.6e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—muscle cancer	1.31e-05	7.52e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	1.3e-05	7.5e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—muscle cancer	1.3e-05	7.5e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—muscle cancer	1.27e-05	7.32e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—muscle cancer	1.2e-05	6.9e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—muscle cancer	1.19e-05	6.84e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—muscle cancer	1.11e-05	6.38e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—muscle cancer	1.1e-05	6.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—muscle cancer	1.07e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—muscle cancer	1.07e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—muscle cancer	1e-05	5.76e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—muscle cancer	9.97e-06	5.74e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—muscle cancer	9.87e-06	5.68e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—muscle cancer	9.84e-06	5.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—muscle cancer	8.35e-06	4.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—muscle cancer	8.07e-06	4.65e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—muscle cancer	8.07e-06	4.65e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—muscle cancer	7.83e-06	4.51e-05	CbGpPWpGaD
